Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes. - Wikidata - wikimedia - TriplyDB

Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.

Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.

http://www.wikidata.org/entity/Q37868449

about

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer.FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies.Understanding pancreatic cancer genomes.Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance.Can we move towards personalised pancreatic cancer therapy?Molecular diagnostics in pancreatic cancer

P2860

Q24595981-1594D167-6603-461E-9B08-31DC38C792DF Q34639858-168900E0-685E-458C-A6BE-AD205C8427BA Q37164249-78D1B1B9-5EC1-4499-B35C-1858C8F06F4E Q38105473-FA67022C-37BA-41DA-87AC-60D18E3394D3 Q39355884-4F6DFDAD-0510-476B-8E86-ED38BD1BEB4F Q57422490-25954D25-E754-413C-BD29-8B765161DBDB Q57422493-FABB2159-6D4C-412B-9313-7528156B54BB

P2860

Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.

http://www.wikidata.org/entity/Q37868449

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@en

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@nl

type

label

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@en

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@nl

prefLabel

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@en

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@nl

P1433

Q37868449-BA6693CB-69C3-456B-A8C9-0F57C441885E

P1476

Q37868449-CCACDD33-131A-4367-96DB-FA6ECF4167EC

P2093

Q37868449-0A258177-4602-42F9-9855-AF83F4009F61

Q37868449-71030A5C-1D78-442E-A758-2E4453EC32B1

P2860

Q37868449-009F3A22-73F1-40B4-A117-70B501939D3C

Q37868449-00DDD367-AB66-493F-B9CA-A8938EDFF488

Q37868449-04389BFB-BA23-43E7-8356-4993C1486868

Q37868449-23887F7A-629D-4BF6-B720-02AC594742F3

Q37868449-23CC8B33-80BA-46FB-A605-588EA330F525

Q37868449-2CCF027B-16C0-4D74-A81C-45FD0E32F6B7

Q37868449-317742E5-B47D-4E73-86DD-43ACEB7250F4

Q37868449-39E57BF4-59E6-4023-92EF-D09B03C26884

Q37868449-45F47F19-5E65-4A8C-B456-5074879C69FA

Q37868449-4617AF71-9D75-4E90-BA7E-E7EC5DA0E332

P2888

Q37868449-EF714C1C-3B51-4501-8FA2-D39D2A11297C

P304

Q37868449-3D98C40B-CB69-411B-AC32-EAF842755C5E

P31

Q37868449-154503BD-7642-4B19-A117-B79805550C28

P356

Q37868449-DCA1A902-C529-49FD-A21B-27FD1057CC40

P433

Q37868449-600B1151-CF41-441C-9B2C-AF0CE93B4E0D

P478

Q37868449-D0C407DA-803E-470D-AEFC-7CF8197AE51C

P50

Q37868449-2E4C687B-ED4A-45BD-872A-51D991180ED9

Q37868449-9C67233C-EFCE-46E4-9A35-AD82AD3BD3E7

Q37868449-CF4AAB16-9303-4A49-8733-D8382E3D4F96

P577

Q37868449-C88C54B2-9FAD-4FED-AD7D-13DAA70FF82A

P698

Q37868449-C24E4F01-89F9-4E85-8753-190D11D82FFB

P921

Q37868449-4A5CE200-AFAE-462E-A004-E6586D8DE736

P356

S00439-011-0990-0

P1433

P1476

Preclinical strategies to defi ...... ally relevant cancer subtypes.

@en

P2093

Christopher J Scarlett

http://www.w3.org/2001/XMLSchema#string

Robert L Sutherland

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic progression and the waiting time to cancer

Oncogenes and Cancer

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

International network of cancer genome projects.

How the fanconi anemia pathway guards the genome

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

Efficient tumour formation by single human melanoma cells

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

P2888

s00439-011-0990-0

P304

93-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00439-011-0990-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21516344

http://www.w3.org/2001/XMLSchema#string

P921